WKN: | 938427 |
ISIN: | CH0010645932 |
Land: | Schweiz |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Chemie |
Weshalb die Givaudan-Aktie
ein AAA-Rating hat,
erfahren Sie im Performance-Check
vom 18. Juli 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2010 | 556,32 | 812,12 | 45,98% |
2 | 2014 | 1.039,63 | 1.491,70 | 43,48% |
3 | 2019 | 2.022,36 | 2.793,01 | 38,11% |
4 | 2021 | 3.443,54 | 4.633,35 | 34,55% |
5 | 2023 | 2.869,09 | 3.747,18 | 30,61% |
6 | 2013 | 798,13 | 1.039,63 | 30,26% |
7 | 2002 | 318,15 | 396,96 | 24,77% |
8 | 2020 | 2.793,01 | 3.443,54 | 23,29% |
9 | 2006 | 532,83 | 652,86 | 22,53% |
10 | 2001 | 262,86 | 318,15 | 21,04% |
11 | 2005 | 451,60 | 532,83 | 17,99% |
12 | 2004 | 383,40 | 451,60 | 17,79% |
13 | 2015 | 1.491,70 | 1.688,13 | 13,17% |
14 | 2024 | 3.747,18 | 4.226,26 | 12,79% |
15 | 2017 | 1.743,90 | 1.926,81 | 10,49% |
16 | 2012 | 737,40 | 798,13 | 8,24% |
17 | 2009 | 519,29 | 556,32 | 7,13% |
18 | 2018 | 1.926,81 | 2.022,36 | 4,96% |
19 | 2016 | 1.688,13 | 1.743,90 | 3,30% |
20 | 2003 | 396,96 | 383,40 | -3,42% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2022 | 4.633,35 | 2.869,09 | -38,08% |
2 | 2008 | 612,18 | 519,29 | -15,17% |
3 | 2011 | 812,12 | 737,40 | -9,20% |
4 | 2007 | 652,86 | 612,18 | -6,23% |
5 | 2025 | 4.226,26 | 4.028,00 | -4,69% |
6 | 2003 | 396,96 | 383,40 | -3,42% |
7 | 2016 | 1.688,13 | 1.743,90 | 3,30% |
8 | 2018 | 1.926,81 | 2.022,36 | 4,96% |
9 | 2009 | 519,29 | 556,32 | 7,13% |
10 | 2012 | 737,40 | 798,13 | 8,24% |
11 | 2017 | 1.743,90 | 1.926,81 | 10,49% |
12 | 2024 | 3.747,18 | 4.226,26 | 12,79% |
13 | 2015 | 1.491,70 | 1.688,13 | 13,17% |
14 | 2004 | 383,40 | 451,60 | 17,79% |
15 | 2005 | 451,60 | 532,83 | 17,99% |
16 | 2001 | 262,86 | 318,15 | 21,04% |
17 | 2006 | 532,83 | 652,86 | 22,53% |
18 | 2020 | 2.793,01 | 3.443,54 | 23,29% |
19 | 2002 | 318,15 | 396,96 | 24,77% |
20 | 2013 | 798,13 | 1.039,63 | 30,26% |